Skip Navigation
JavaScript is disabled in your browser, you must have JavaScript enabled to view this content.
Search:
JavaScript is disabled in your browser, you must have JavaScript enabled to view this content.
Drug Database Search
FDA-approved Drugs
Combination Drugs
Entry and Fusion Inhibitors
Integrase Inhibitors
Non-nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Opportunistic Infection and Other Drugs
Protease Inhibitors
Investigational Drugs
Entry and Fusion Inhibitors
Integrase Inhibitors
Microbicides
Non-nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Opportunistic Infection and Other Drugs
Home
>
Drugs
> Search Results
Text Size
Print
RSS
Order Pubs
Search Results
New Search
Drugs in the integrase inhibitor class of anti-HIV drugs prevent the HIV integrase enzyme from inserting HIV's genetic information into an infected cell's own DNA, halting this critical step of the HIV life cycle.
FDA-approved Drugs
Integrase Inhibitors
Isentress (Isentress)
MK-0518 (Isentress)
MK0158 (Isentress)
RAL (Isentress)
Raltegravir (Isentress)
Investigational Drugs
Integrase Inhibitors
EVG
GS 9137 (elvitegravir)
GS-9137
JTK-303
elvitegravir
Drug News
Phase III Clinical Trial Results show Carregeenan to be Safe but not Effective as a Vaginal Microbicide - February 18, 2008
FDA Approves New NNRTI, Etravirine - January 18, 2008
FDA Approves the First Integrase Inhibitor, Raltegravir - October 12, 2007
FDA Antiviral Drugs Advisory Committee Recommends Accelerated Approval of Raltegravir - September 5, 2007
FDA Approves HIV-Entry Inhibitor Maraviroc - August 6, 2007
More..
More About Drugs
Drug Dosing Toolkit
Drugs Used for the Treatment of HIV Infection
Drugs Used in the Treatment of Pediatric HIV Infection
Drugs Used to Treat Complications of HIV/AIDS
Antiretroviral Drug Toxicities Chart
National Library of Medicine Drug Information Portal
More..